Related Experiment Video
Updated: Mar 31, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Targeting epigenetic regulations in cancer
Bo Ning1, Wenyuan Li2, Wei Zhao1
1Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030, USA.
Abstract:
Epigenetic regulation of gene expression is a dynamic and reversible process with DNA methylation, histone modifications, and chromatin remodeling. Recently, groundbreaking studies have demonstrated the importance of DNA and chromatin regulatory proteins from different aspects, including stem cell, development, and tumor genesis. Abnormal epigenetic regulation is frequently associated with diseases and drugs targeting DNA methylation and histone acetylation have been approved for cancer therapy. Although the network of epigenetic regulation is more complex than people expect, new potential druggable chromatin-associated proteins are being discovered and tested for clinical application. Here we review the key proteins that mediate epigenetic regulations through DNA methylation, the acetylation and methylation of histones, and the reader proteins that bind to modified histones. We also discuss cancer associations and recent progress of pharmacological development of these proteins.
Insights
Epigenetic regulation controls gene expression via DNA methylation and histone modifications. Targeting these epigenetic mechanisms shows promise for cancer therapy and disease treatment.
Area of Science:
- Molecular Biology
- Genetics
- Epigenetics
Background:
- Epigenetic regulation, including DNA methylation and histone modifications, dynamically controls gene expression.
- These regulatory mechanisms are crucial in stem cell biology, development, and tumor genesis.
- Aberrant epigenetic regulation is linked to various diseases, notably cancer.
Purpose of the Study:
- To review key proteins involved in epigenetic regulation via DNA methylation, histone acetylation, and histone methylation.
- To discuss the role of reader proteins that bind to modified histones.
- To explore the association of these epigenetic factors with cancer and recent pharmacological developments.
Main Methods:
- Literature review of studies on epigenetic regulatory proteins.
- Analysis of proteins mediating DNA methylation and histone modifications.
- Examination of reader proteins interacting with modified histones.
- Review of cancer associations and drug development targeting epigenetic proteins.
Main Results:
- Identified key proteins mediating DNA methylation, histone acetylation, and histone methylation.
- Highlighted the function of reader proteins in interpreting epigenetic marks.
- Demonstrated the significant association between epigenetic dysregulation and cancer development.
- Summarized progress in developing drugs targeting epigenetic modifications for cancer therapy.
Conclusions:
- Epigenetic regulation is a complex network involving DNA methylation, histone modifications, and reader proteins.
- Abnormal epigenetic regulation is a hallmark of diseases, particularly cancer.
- Targeting epigenetic mechanisms offers promising therapeutic strategies for cancer and other diseases.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Mitogens and the Cell Cycle

